483 Response AstraZeneca Pharmaceuticals, LP Mar 2016

Thomas Arista FDA, Massoud Motamed FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals, LP - Coppell, TX, United States facility and issued inspectional observation (via FDA 483) on 29 Mar 2016.

Product details

  • Category:
  • Inspection end: 29 Mar 2016
  • Location: Coppell, United States
  • FEI: 3010199915
Add To Cart